Last updated: August 2, 2023
Sponsor: Bambino Gesù Hospital and Research Institute
Overall Status: Active - Recruiting
Phase
N/A
Condition
Dyslexia
Treatment
Active HD-tDCS over V1
Active HD-tDCS over V5/MT
Sham HD-tDCS over V5/MT or V1
Clinical Study ID
NCT05972200
3073_OPBG_2023
Ages 8-13 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Italian speakers right-handed children and adolescents with dyslexia (DSM-5, APA 2013);
- Word/nonword/text reading accuracy and/or speed at least 2 Standard Deviations belowthe mean for school-age;
- nv IQ ≥ 85;
- normal hearing and normal or corrected-to-normal vision.
Exclusion
Exclusion Criteria:
- Having a comorbidity with other primary psychiatric/neurological diagnosis (e.g.,depression, anxiety, autism, ADHD);
- Having a personal history of neurological/medical/genetic diseases;
- Having ongoing drug treatment influencing brain function;
- Having epilepsy o family history of epilepsy.
Study Design
Total Participants: 36
Treatment Group(s): 3
Primary Treatment: Active HD-tDCS over V1
Phase:
Study Start date:
September 01, 2023
Estimated Completion Date:
August 31, 2026
Study Description
Connect with a study center
Bambino Gesù Hospital and Research Institute
Roma, 00165
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.